Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

OraSure Technologies to Hold Virtual Annual Meeting of Stockholders on May 18, 2021

OSUR

BETHLEHEM, Pa., May 12, 2021 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), announced that its 2021 Annual Meeting of Stockholders will be a completely virtual meeting, conducted as a live webcast beginning at 10:00 a.m. Eastern (7:00 a.m. Pacific) on Tuesday, May 18, 2021.

In order to access the meeting, a stockholder or a person holding a valid stockholder proxy may go to www.virtualshareholdermeeting.com/OSUR2021 at least five (5) minutes prior to the start of the meeting to log in. A stockholder must enter the control number that was provided in the Notice Regarding the Availability of Proxy Materials, proxy card or other proxy materials received by such stockholder in order to vote and ask questions that are germane to the business being discussed at the meeting.

A replay of the webcast will be available 24 hours after the meeting is concluded and will be archived on OraSure Technologies' website for seven days.

About OraSure Technologies

OraSure Technologies empowers the global community to improve health and wellness by providing access to accurate, essential information. Together with its wholly-owned subsidiaries, DNA Genotek, Diversigen and Novosanis, OraSure provides its customers with end-to-end solutions that encompass tools, services and diagnostics. The OraSure family of companies is a leader in the development, manufacture, and distribution of rapid diagnostic tests, sample collection and stabilization devices, and molecular services solutions designed to discover and detect critical medical conditions. OraSure’s portfolio of products is sold globally to clinical laboratories, hospitals, physician’s offices, clinics, public health and community-based organizations, research institutions, government agencies, pharma, commercial entities and direct to consumers. For more information on OraSure Technologies, please visit www.orasure.com .

Company Contacts:
Investor Contact: Media Contact:
Sam Martin Jeanne Mell
Argot Partners OraSure Technologies, Inc.
(212) 600-1902 (484) 353-1575
orasure@argotpartners.com media@orasure.com




Primary Logo